Apellis Pharmaceuticals (NASDAQ:APLS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Apellis Pharmaceuticals (APLS) operate in?

Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.

Open	$30.76
Close	-
Volume / Avg.	427.36K / 1.59M
Day Range	$30.23 - $31.05
52 Wk Range	30.74 - 73.80
Market Cap	$3.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	17.33%
Days to Cover	10.93

Recent News

CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

What's Going With Apellis Pharmaceuticals Stock Friday?

Apellis Pharmaceuticals shares are moving lower after the Committee for Medicinal Products for Human Use of the European Medicines Agency confirmed its June 2024 negative opinion following re-examination.

Dylan Berman

Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases

Swedish Orphan Biovitrum and Apellis Pharmaceuticals released topline results from the Phase 3 VALIANT study of pegcetacoplan for C3 glomerulopathy and IC-MPGN. The study met primary and secondary endpoints, showing proteinuria and kidney inflammation reductions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$30.76
Close	-
Volume / Avg.	427.36K / 1.59M
Day Range	$30.23 - $31.05
52 Wk Range	30.74 - 73.80
Market Cap	$3.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	17.33%
Days to Cover	10.93

About Apellis Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Apellis Pharmaceuticals (APLS) stock?

You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.

View our list of the best stock brokerages

Who are Apellis Pharmaceuticals (APLS) competitors?

Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Apellis Pharmaceuticals (APLS) stock?

Apellis Pharmaceuticals has a consensus price target of $69.17.

What is the current price for Apellis Pharmaceuticals (APLS)?

The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $30.75 last updated September 25, 2024 at 11:48 AM EDT.

Does Apellis Pharmaceuticals (APLS) pay a dividend?

There are no upcoming dividends for Apellis Pharmaceuticals.

When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?

Apellis Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Apellis Pharmaceuticals (APLS) going to split?

There is no upcoming split for Apellis Pharmaceuticals.

What sector and industry does Apellis Pharmaceuticals (APLS) operate in?

Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge